Research Article
No access
Published Online: 9 October 2014

Discriminating the Effects of Cannabis sativa and Cannabis indica: A Web Survey of Medical Cannabis Users

Publication: The Journal of Alternative and Complementary Medicine
Volume 20, Issue Number 10

Abstract

Objective: To evaluate the opinions of medical cannabis (MC) users on the effects of Cannabis indica vs. those of Cannabis sativa on conditions and symptoms through an online survey.
Design: Survey of 95 non–randomly assigned MC users. A two-sided chi-square test followed by Bonferroni post hoc multiple comparison and Fisher exact test were used to determine correlations. The Cronbach α was used to determine internal consistency.
Setting: Announcements on 13 MC websites with links to SurveyMonkey.com.
Participants: Self-identified MC users.
Intervention: Web survey.
Outcome measures: Species effects were compared regarding health symptoms, conditions, purpose, route, and trust in product label.
Results: Trust in the purity, the route of administration, or the purpose (recreational vs. medicinal) did not differ between the two species. A preference for C. indica was statistically significant for pain management (p=0.001), helping with sedation (p=0.015), and sleep (p<0.001). C. sativa was preferred for euphoria (p<0.001) and enhancing energy (p=0.022). The conditions reaching statistical significance for C. indica preference were: nonmigraine headaches (p=0.042), glaucoma (p=0.036), neuropathy (p=0.024), spasticity (p=0.048), seizures (p=0.031), insomnia (p<0.001), and joint pain (p=0.048). For C. sativa, no conditions reached significance. The MC websites' descriptions of effects that agreed with the survey results are listed. Some conditions had very few respondents. The internal consistency/reliability (Cronbach α) was adequate for the condition scale but not for the symptom survey.
Conclusion: In this anonymous Web survey, which had limitations, the two species had different effect associations on symptoms and conditions, possibly because of ingredient differences. Future surveys and subsequent prospective definitive trials are needed to confirm the findings.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Elphick MR, Egertova M. The neurobiology and evolution of cannabinoid signalling. Philos Trans R Soc Lond B Biol Sci 2001;356:381–408.
2.
Parker LA, Mechoulam R, Schlievert C. Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats. Neuroreport 2002;13:567–570.
3.
Vignot S, Besse B, de la Motte Rouge T, et al. [Cannabis and cancer]. Bull Cancer 2006;93:163–170.
4.
Hillig K, Mahlberg P. A chemotaxonamic analysis of cannabinoid variation in cannabis (Cannabaceae). Am J Botany 2004;91:966–975.
5.
Upton R, ElSohly M, Romm A, Russo E, Sexton M, eds. Cannabis Inflorescence, Cannabis spp. Scotts Valley: American Herbal Pharmacopoeia; 2013.
6.
ElSohly MA, Ross SA, Mehmedic Z, et al. Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980–1997. J Forensic Sci 2000;45:24–30.
7.
Ware MA, Wang T, Shapiro S, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ. 2010;182:E694–701.
8.
Vann RE, Gamage TF, Warner JA, et al. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol. Drug Alcohol Depend. 2008;94:191–198.
9.
Rog DJ, Nurmikko TJ, Young CA. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. Clin Ther 2007;29:2068–2079.
10.
Nicholson AN, Turner C, Stone BM, Robson PJ. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 2004;24:305–313.
11.
Fattore L, Fratta W. How important are sex differences in cannabinoid action? Br J Pharmacol. 2010;160:544–548.
12.
Lopez HH. Cannabinoid-hormone interactions in the regulation of motivational processes. Horm Behav. 2010;58:100–110.
13.
Viveros MP, Marco EM, Lopez-Gallardo M, et al. Framework for sex differences in adolescent neurobiology: a focus on cannabinoids. Neurosci Biobehav Rev 2011; 35:1740–1751.
14.
Kellert BA, Nguyen MC, Nguyen C, et al. Estrogen rapidly attenuates cannabinoid-induced changes in energy homeostasis. Eur J Pharmacol 2009;622:15–24.
15.
Ware MA, Adams H, Guy GW. The medicinal use of cannabis in the UK: results of a nationwide survey. Int J Clin Pract 2005;59:291–295.
16.
Gieringer D, Hazekamp A. How accurate is potency testing. O'Shaughnessy's. 2011;17.
17.
Provision of marijuana and other compounds for scientific research - recommendations of The National Institute on Drug Abuse National Advisory Council 1998 growth of cannabis is legally restricted. Online document at: http://archives.drugabuse.gov/about/organization/nacda/MarijuanaStatement.html Accessed April 12, 2013.
18.
Brill NQ, Crumpton E, Frank IM, et al. The marijuana problem. Ann Intern Med. 1970;73:449–465.

Information & Authors

Information

Published In

cover image The Journal of Alternative and Complementary Medicine
The Journal of Alternative and Complementary Medicine
Volume 20Issue Number 10October 2014
Pages: 787 - 791
PubMed: 25191852

History

Published online: 9 October 2014
Published in print: October 2014
Published ahead of print: 5 September 2014

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Daniel D. Pearce
Veterans Administration, Loma Linda University Health System, Claremont, CA.
Katherine Mitsouras
College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA.
Kristopher J. Irizarry
College of Veterinary Medicine, Western University of Health Sciences, Pomona, CA.

Notes

Address correspondence to:Daniel D. Pearce, DO, AAHIVMS, FACOIVeterans AdministrationLoma Linda University Health System850 Hood DriveClaremont, CA 91711E-mail: [email protected]

Author Disclosure Statement

No competing financial relationships exist.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Figures

Tables

Media

Share

Share

Copy the content Link

Share on social media

Back to Top